Testing Anifrolumab against a placebo for systemic lupus erythematosus
Explore this study →
Sites in Calgary, Toronto and 1 more city
Official title: An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus · AstraZeneca